中科美菱(920992) - 2025 Q4 - 年度业绩

Financial Performance - The company achieved operating revenue of CNY 308.54 million, a year-on-year increase of 4.32%[4] - Net profit attributable to shareholders reached CNY 19.11 million, up 5.64% compared to the previous year[4] - Net profit attributable to shareholders after deducting non-recurring gains and losses surged by 160.24% to CNY 9.57 million[4] - Basic earnings per share increased to CNY 0.1975, reflecting a growth of 5.61%[4] - Total assets at the end of the reporting period amounted to CNY 749.93 million, a 0.62% increase from the beginning of the period[5] - Shareholders' equity attributable to the company reached CNY 625.05 million, up 2.18% from the start of the period[5] Strategic Focus - The company is focusing on the life sciences sector and enhancing its product competitiveness through a comprehensive low-temperature storage solution[6] - The company is actively expanding its domestic and international markets, emphasizing value creation for users[6] - The company is implementing refined cost control and operational efficiency measures to enhance overall capabilities[6] Cautionary Notes - The financial data presented is preliminary and has not been audited, cautioning investors about potential risks[8]

Zhongke Meiling Cryogenics-中科美菱(920992) - 2025 Q4 - 年度业绩 - Reportify